(CN) — A federal judge has temporarily blocked an expected $4 billion slash to funding for biomedical research after a group ...

The cystic fibrosis treatment leader exceeded revenue expectations, but missed slightly on earnings per share.

(CN) — A coalition of 22 state attorneys general is taking aim at a Trump administration policy that would slash funding for ...

The fourth-quarter earnings season for the biotech sector is in full swing this week. A few bigwigs have already reported results. Among these, Bristol Myers reported better-than-expected ...

Janney Montgomery Scott LLC lowered its holdings in Moderna, Inc. (NASDAQ:MRNA – Free Report) by 21.0% in the fourth quarter, ...

We recently compiled a list of the These 10 Firms Were Last Week’s Worst Performers. In this article, we are going to take a ...

To come up with last week’s worst performers, we considered only the stocks with at least $2 billion in market capitalization ...

To illustrate that point, let's discuss two stocks in the biotech industry that have moved in opposite directions so far this ...

We recently compiled a list of the 12 Best Healthcare Stocks to Buy According to Analysts. In this article, we are going to ...

An image that is spreading widely online claims that Moderna had created its COVID-19 vaccine two years before the pandemic ...